Atara Biotherapeutics
Matthew Fust is an advisor to life sciences companies. He was Executive Vice President and Chief Financial Officer of Onyx Pharmaceuticals from January 2009 through its acquisition in October 2013. From May 2003 to December 2008, Matthew served as Chief Financial Officer of Jazz Pharmaceuticals.
This person is not in the org chart
This person is not in any offices
Atara Biotherapeutics
4 followers
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases.